Related Experiment Video
Updated: Aug 20, 2025

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
William J Anderson1, Bradley T Smith2
1Department of Ophthalmology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Purpose:
To report a case evaluating PDT and eplerenone therapy in a patient with bilateral bullous central serous chorioretinopathy.
Observations:
A 30-year-old male was referred for worsening bilateral bullous central serous chorioretinopathy (bCSCR) despite oral eplerenone therapy. Photodynamic therapy (PDT) was performed in the right eye with significant improvement of bullous retinal detachment, near-complete resolution of subfoveal subretinal fluid, and improvement of vision from 20/200 to 20/25. The left eye had persistent subretinal fluid despite continued eplerenone therapy. Neither eye worsened when eplerenone was withdrawn. Total follow up was 3.5 years.
Conclusions And Importance:
This case demonstrates a significant and durable effect of PDT in bullous CSCR and suggests a lack of response to eplerenone.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Nephrotic Syndrome II : Assessment and Medical Management

